JPRN-UMIN000008534已完成4 期
A Phase IV Clinical Trial of EMPYNASE P Tablets 18000 in Patients with Chronic Respiratory Disease. - A Phase IV Clinical Trial of EMPYNASE P Tablets 18000 in Patients with Chronic Respiratory Disease.
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 240
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •-Patients with a history of drug hypersensitivity. -Patients with blood clotting defect. -Elderly patients with depressed physiological function and who are judged to be inadequate to participate in this trial by the principal investigator or co-investigator. -Patients who are needed domiciliary oxygen therapy. -Patients whose general status are quite worsened.
研究者
相似试验
已完成
4 期
A Phase IV Clinical Trial of EMPYNASE P Tablets 18000 in Patients with ankle swelling after lateral ankle sprain injuries.ankle swelling after lateral ankle sprain injuries.JPRN-UMIN000009218Kaken Pharmaceutical Co., LTD200
已完成
4 期
A Phase 4 clinical trial of EMPYNASE P tablets 18000 in patients with chronic sinusitischronic sinusitisJPRN-UMIN000008633KAKEN PHARMACEUTICAL CO., LTD.260
进行中（未招募）
不适用
A Phase III trial assessing the pharmacodynamic efficacy and the tolerability of Grazax® treatment initiated in the grass pollen season in subjects with seasonal grass pollen induced rhinoconjunctivitis - Grazax® in-seasoEUCTR2007-006009-26-DEALK-Abelló A/S295
进行中（未招募）
不适用
A Phase III trial assessing the pharmacodynamic efficacy and the tolerability of Grazax® treatment initiated in the grass pollen season in subjects with seasonal grass pollen induced rhinoconjunctivitis - Grazax® in-seasoGrass pollen induced rhinoconjunctivitisMedDRA version: 9.1Level: LLTClassification code 10039097Term: RhinoconjunctivitisEUCTR2007-006009-26-ATALK-Abelló A/S250
招募中
1 期
Perispinal Etanercept therapy in Australian patients with chronic stroke.Chronic StrokeStroke - IschaemicStroke - HaemorrhagicACTRN12615001377527Griffith University80